Iridex (IRIX) FCF Margin (2011 - 2026)
Iridex's quarterly FCF Margin came in at 12.17% in Q2 2026, down 242.0% year-on-year from 8.57% in Q2 2025, and down 471.01% quarter-over-quarter from 3.28% in Q1 2026.
Iridex has reported FCF Margin for 16 years, with the latest figure at 12.17% in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 242.0% year-over-year to 12.17%; the trailing twelve-month figure through Apr 2026 stood at 4.82% (up 913.0% YoY), and the FY2026 full-year result was 4.29%, up 1071.0% from the prior year.
- FCF Margin for Q2 2026 stood at 12.17%, down from 3.28% in the prior quarter.
- The five-year high for FCF Margin was 37.24% in Q1 2022, with the low at 26.54% in Q3 2024.
- Average FCF Margin over 5 years is 9.82%, with a median of 10.75% recorded in 2022.
- Year-over-year, FCF Margin sank 12280 bps in 2022 and jumped 1716 bps in 2025.
- Tracing IRIX's FCF Margin over 5 years: stood at 11.01% in 2022, then soared by 31 bps to 7.6% in 2023, then retreated by 29 bps to 9.82% in 2024, then increased by 4 bps to 9.38% in 2025, then decreased by 30 bps to 12.17% in 2026.
- The last three FCF Margin figures came in at 12.17% (Q2 2026), 3.28% (Q1 2026), and 9.38% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | -12.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -12.17% |
| Jan 3, 2026 | 3.28% |
| Sep 27, 2025 | -9.38% |
| Jun 28, 2025 | -3.02% |
| Mar 29, 2025 | -9.75% |
| Dec 28, 2024 | -9.82% |
| Sep 28, 2024 | -26.54% |
| Jun 29, 2024 | -10.50% |
| Mar 30, 2024 | -14.04% |
| Dec 30, 2023 | -7.60% |
| Sep 30, 2023 | -14.51% |
| Jul 1, 2023 | -9.00% |
| Apr 1, 2023 | -21.06% |
| Dec 31, 2022 | -11.01% |
| Oct 1, 2022 | -14.78% |
| Jul 2, 2022 | -19.56% |
| Apr 2, 2022 | -24.49% |
| Jan 1, 2022 | 37.24% |
| Apr 3, 2021 | 98.31% |
| Sep 26, 2020 | 4.57% |
| Jun 27, 2020 | -32.11% |
| Mar 28, 2020 | -16.86% |
| Dec 28, 2019 | -1.63% |
| Sep 28, 2019 | -24.17% |
| Jun 29, 2019 | -13.50% |
| Mar 30, 2019 | -36.47% |
| Dec 29, 2018 | -18.31% |
| Sep 29, 2018 | -25.95% |
| Jun 30, 2018 | -23.54% |
| Mar 31, 2018 | -31.56% |
| Dec 30, 2017 | -9.41% |
| Sep 30, 2017 | -18.32% |
| Jul 1, 2017 | 7.78% |
| Apr 1, 2017 | -18.73% |
| Dec 31, 2016 | -4.86% |
| Oct 1, 2016 | -21.02% |
| Jul 2, 2016 | 8.60% |
| Apr 2, 2016 | 3.66% |
| Jan 2, 2016 | -34.10% |
| Apr 4, 2015 | 2.04% |
| Sep 27, 2014 | 10.96% |
| Jun 28, 2014 | 5.12% |
| Mar 29, 2014 | 5.20% |
| Dec 28, 2013 | -6.94% |
| Sep 28, 2013 | 5.54% |
| Jun 29, 2013 | 11.05% |
| Mar 30, 2013 | -4.74% |
| Dec 29, 2012 | 3.50% |
| Sep 29, 2012 | 1.61% |
| Jun 30, 2012 | -7.33% |
| Mar 31, 2012 | -16.41% |
| Dec 31, 2011 | 18.14% |
| Oct 1, 2011 | 12.69% |
| Jul 2, 2011 | 2.10% |
| Apr 2, 2011 | -9.31% |